CHEMICAL THERAPIES

These are some of the therapies which should be approached with caution and discussed with your doctor, because they may be harmful in some circumstances.

714-X Therapy
It has been proposed that 714-X works by protecting, stabilizing, and reactivating the patient`s immune system, so the body can defend itself against tumor growth and metastasis. The camphor component of 714-X is purportedly attracted to cancer cells, where the added nitrogen is released, thus preventing tumor cells from depleting the nitrogen required by normal cells, including immune system cells, for proper metabolism and function.

The 714X therapy consists of one injection a day, in the groin`s lymphatic nodes, for consecutive twenty-one days, succeeded by two days of rest. Longer and more intensive 714X treatment may be needed for patients diagnosed with advanced cancer. However, vitamin E and vitamin B12 should not consumed with the 714X therapy.

The 714X therapy combined with other forms of alternative therapies, treated by Harvey Bigelson, M.D., resulted in an effectiveness between sixty and eighty percent. No, clinical trials, or case reports have been published in peer-reviewed, scientific journals to support the safety or the efficacy of 714-X.

Antineoplaston Therapy
Antineoplaston therapy is based upon the theory that human body contains a Biochemical Defense System (BDS), which has no association with the immune system. BDS contains polypeptides, which are a short chain of amino acids, that are capable of reprograming the cancerous cells. The antineoplastons, or polypeptides, inhibit the growth of cancer by replacing carcinogenic (cancer causing) molecules within the cell`s DNA. Therefore, the antineoplastons are able to produce a normal, reproductive state for DNA.

Antineoplastons, which can be artificially manufactured as well as obtained from urine and blood serum, may be effective on patients who have been diagnosed with cancer early, on patients who have been diagnosed with terminal cancer, on cancer prevention, as well as on benign(non-cancerous) tumors and genital warts. Outpatient treatment (treatment received at a hospital that does not require a overnight stay) is usually used on antineoplaston patients. A 1977 study, indicated that antineoplaston therapy improved eighty-six percent of the patients with advanced cases of cancer and few side effects were observed. Antineoplastons may also be consumed orally. Conventional therapy may be used with antineoplaston therapy, which reduces the harmful effects of chemotherapy due to the decrease in dosages as well as the stimulation of bone marrow functions by antineoplastons.

Hydrazine Sulfate
Hydrazine Sulfate has been investigated as a treatment for cancer for more than 30 years. It has been studied, in combination with established treatments, as a first-line agent in cancer chemotherapy. It has also been investigated as a treatment for cancer-related anorexia (loss of appetite) and cachexia (loss of muscle mass and body weight). Similar to other hydrazine compounds, it has a core chemical structure consisting of two nitrogen atoms and four hydrogen atoms. It is a chemical that has been studied as an antitumor agent and as a treatment for the body wasting associated with advanced cancer. It has been claimed that hydrazine sulfate limits the ability of tumors to obtain glucose, which is a type of sugar, used by cells to create energy.

However, there is only limited evidence from animal studies that hydrazine sulfate has anticancer activity. Hydrazine sulfate has shown no antitumor activity in clinical trials and data concerning its efficacy in treating cancer-related cachexia are inconclusive. Even though patients often benefit to hydrazine sulfate therapy by gaining weight, the chemical may be harmful to one`s health. Hydrazine sulfate therapy may induce nausea, dizziness, itching, drowsiness, and euphoria (a state in which a person feels extreme levels of happiness).